Notice of Correction to Funds Available and Anticipated Number of Awards for RFA-FD-14-009 "Dissolution Methods for Suspension and Emulsion Ocular Drug Products (U01)"
RFA-FD-14-009
Notice Number: NOT-FD-14-005
Key Dates
Release Date: April 9, 2014
RFA-FD-14-009
Issued by
U.S. Food and Drug Administration
Purpose
The purpose of this Notice is to correct the Funds Available and Anticipated Number of Awards for RFA-FD-14-009
Now Reads:
Funds Available and Anticipated Number of Awards |
The FDA and partner components intend to commit an estimated total of $250,000 to fund 1 award. |
Should Read:
Funds Available and Anticipated Number of Awards |
The FDA and partner components intend to commit an estimated total of $250,000 per award. Up to 2 awards may be funded. |
Inquiries
Please direct all inquiries to:
Gladys Melendez (Bohler)
Food and Drug Administration (FDA)
Telephone: 301-515-0642
Email: gladys.bohler@fda.hhs.gov
Department of Health
and Human Services (HHS)
and Human Services (HHS)
